Request Deal Involvement
Bayer completed the acquisition of KaNDy Therapeutics for $425m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Morgan Stanley
legal advisors
Linklaters
pr advisors
Finsbury Glover Hering
financial advisors
Goldman Sachs
pr advisors
Consilium Strategic Communications
legal advisors
Goodwin Procter
pr advisors
Instinctif Partners
legal advisors
Goodwin Procter
legal advisors
A&L Goodbody
or
Principals
bidder
BAYER AG
target
KANDY THERAPEUTICS LTD
vendor
FORBION CAPITAL PARTNERS
vendor
ORBIMED ADVISORS LLC
vendor
FOUNTAIN HEALTHCARE PARTNERS
vendor
ADVENT VENTURE PARTNERS
vendor
LONGITUDE CAPITAL MANAGEMENT CO LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite